This strategy has been reported in five patients [(55, 83–86), reviewed in (18)] and resulted in a decrease in serum T3 concentration and improvement of biochemical markers and clinical symptoms of the peripheral thyrotoxicosis (decrease in serum SHBG concentrations, increase in body weight, decrease in heart rate). The gene discussed is SHBG; the disease is thyrotoxicosis.